FTO, the first and important demethylase of m6A, has been reported as an oncogene in different cancers such as cervical squamous cell carcinoma [17], endometrial cancer [42], etc. However, the roles of FTO in breast cancer initiation and progression are yet fully understood. This evidence concerns the gene FTO and breast carcinoma.